Clinical Infectious Diseases
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Contamination of Bone Marrow Products with an Actinomycete ResemblingMicrobacteriumSpecies and Reinfusion into Autologous Stem Cell and Bone Marrow Transplant Recipients
2003
-
Lack of female urinary inhibitors to Chlamydia trachomatis nucleic acid amplification in the Gen-Probe APTIMA Combo 2 assay
2001
-
Outbreak of listeria-associated birth complications linked with homemade Mexican-style cheese, North Carolina, 2000
2001
-
Use of Zanamivir to control an outbreak of influenza A in a nursing home
2000
-
An Outbreak of Vancomycin-Dependent Enterococcus faecium in a Bone Marrow Transplant Unit
1999
-
Evidence of immunologic priming in measles seronegative children using IgG avidity and IgM responses to revaccination.
1996
-
Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial.
79:615-625.
2024
-
Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients With Suspected or Known COVID-19 (July 2020).
78:e133-e149.
2024
-
Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients With Suspected or Known COVID-19 (November 2021).
78:e230-e249.
2024
-
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 (June 2020).
78:e106-e132.
2024
-
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020).
78:e150-e169.
2024
-
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020).
78:e83-e102.
2024
-
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).
78:e250-e349.
2024
-
Rapid Guidelines to Address the Changing COVID-19 Pandemic.
78:e81-e82.
2024
-
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023).
78:e350-e384.
2024
-
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (June 2021).
78:e208-e229.
2024
-
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023).
78:e385-e415.
2024
-
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (January 2021).
78:e170-e207.
2024
-
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
78:562-572.
2024
-
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing.
ciae121.
2024
-
More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?.
78:324-329.
2024
-
SARS-CoV-2 Exposures at a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccination Era: A Randomized Trial Is Possible During the Pandemic.
77:1656-1658.
2023
-
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review.
77:1023-1031.
2023
-
Coronavirus Disease 2019 Vaccination Is Associated With Reduced Outpatient Antibiotic Prescribing in Older Adults With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2: A Population-Wide Cohort Study.
77:362-370.
2023
-
Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults.
77:303-311.
2023
-
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
76:2010-2013.
2023
-
Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status.
76:1567-1575.
2023
-
How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies.
75:1449-1452.
2022
-
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
75:e585-e593.
2022
-
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel.
74:1691-1695.
2022
-
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.
74:1686-1690.
2022
-
Re: It Is Time to Address Airborne Transmission of COVID-19.
73:e3981-e3982.
2021
-
The Critical Need for Pooled Data on Coronavirus Disease 2019 in African Children: An AFREhealth Call for Action Through Multicountry Research Collaboration.
73:1913-1919.
2021
-
Consensus (Convergence of Opinion on Recommendations and Evidence [CORE]) Versus Systematic (Grading of Recommendations Assessment, Development, and Evaluation [GRADE]) Approach to Development of Guidelines for Community-acquired Pneumonia.
73:e1476-e1477.
2021
-
Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antibiotic Therapies: A Systematic Review.
73:e1696-e1705.
2021
-
Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel.
73:e1329-e1336.
2021
-
Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010–2011 to 2015–2016 Seasons in Ontario, Canada.
73:e1191-e1199.
2021
-
C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study.
73:e383-e390.
2021
-
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.
72:e799-e805.
2021
-
Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
72:1657-1659.
2021
-
Pandemic Planning in Homeless Shelters: A Pilot Study of a Coronavirus Disease 2019 (COVID-19) Testing and Support Program to Mitigate the Risk of COVID-19 Outbreaks in Congregate Settings.
72:1639-1641.
2021
-
Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)–Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
72:1016-1023.
2021
-
Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study.
71:e439-e448.
2020
-
Age-Specific Incidence of Influenza A Responds to Change in Virus Subtype Dominance.
71:e195-e198.
2020
-
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
71:905-913.
2020
-
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
71:e1-e36.
2020
-
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus.
71:363-371.
2020
-
Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin–producing Escherichia coli–infected Children.
70:1643-1651.
2020
-
Clinical Correlates of Human Immunodeficiency Virus–1 (HIV-1) DNA and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With Sustained Virologic Suppression for at Least 5 Years.
70:859-866.
2020
-
Reply to Coussement et al.
70:988-989.
2020
-
Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017.
69:980-986.
2019
-
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
69:970-979.
2019
-
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.
68:1611-1615.
2019
-
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.
68:e83-e110.
2019
-
Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
68:1675-1683.
2019
-
The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.
68:788-794.
2019
-
Pediatric Investigators Collaborative Network on Infections in Canada Study of Respiratory Syncytial Virus–associated Deaths in Pediatric Patients in Canada, 2003–2013.
68:113-119.
2019
-
Reply to Stern et al.
67:1467-1468.
2018
-
Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae.
66:1282-1285.
2018
-
Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis.
66:346-354.
2018
-
Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus–Exposed, Uninfected Infants in Malawi: The BAN Study.
65:575-580.
2017
-
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.
65:13-19.
2017
-
Something New for Community-Acquired Pneumonia?.
63:1681-1682.
2016
-
Galactomannan, β-D-Glucan, and Polymerase Chain Reaction–Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
63:1340-1348.
2016
-
Executive Summary: Management of Adults With Hospital-acquired and
Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious
Diseases Society of America and the American Thoracic Society.
63:575-582.
2016
-
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.
63:e61-e111.
2016
-
Shiga Toxin–ProducingEscherichia coliInfection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
62:1251-1258.
2016
-
Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
62:S161-S167.
2016
-
Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.
62:S168-S174.
2016
-
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?.
62:919-926.
2016
-
Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
62:139-147.
2016
-
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons.
62:242-249.
2016
-
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform: Figure 1..
61:S141-S146.
2015
-
Immunodeficiency at Start of Antiretroviral Therapy: The Persistent Problem of Late Presentation to Care.
60:1128-1130.
2015
-
Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts.
60:154-156.
2015
-
Previous Antibiotic Exposure and Antimicrobial Resistance in Invasive Pneumococcal Disease: Results From Prospective Surveillance.
59:944-952.
2014
-
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia.
59:51-61.
2014
-
Addressing the Achilles' Heel in the HIV Care Continuum for the Success of a Test-and-Treat Strategy to Achieve an AIDS-Free Generation.
59:S21-S27.
2014
-
Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials.
58:1297-1307.
2014
-
Burden of HIV-Related Cytomegalovirus Retinitis in Resource-Limited Settings: A Systematic Review.
57:1351-1361.
2013
-
Missed Opportunities for Hepatocellular Carcinoma Screening in an HIV/Hepatitis C Virus-Coinfected Cohort.
57:1339-1342.
2013
-
Herpes Simplex Virus Type 2 Coinfection Does Not Accelerate CD4 Count Decline in Untreated HIV Infection.
57:448-457.
2013
-
Low Serum 25-Hydroxyvitamin D Level and Risk of Upper Respiratory Tract Infection in Children and Adolescents.
57:392-397.
2013
-
Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis.
56:961-967.
2013
-
Association Between Corticosteroids and Infection, Sepsis, and Infectious Death in Pediatric Acute Myeloid Leukemia (AML): Results From the Canadian Infections in AML Research Group.
55:1608-1614.
2012
-
Outbreak of Carbapenem-Resistant Enterobacteriaceae Containing blaNDM-1, Ontario, Canada.
55:e109-e117.
2012
-
Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis.
55:651-662.
2012
-
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans.
55:19-25.
2012
-
Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS.
54:1465-1472.
2012
-
Executive Summary: IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults.
54:1041-1045.
2012
-
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults.
54:e72-e112.
2012
-
Methicillin-Resistant Staphylococcus aureus and Community-Acquired Pneumonia: An Evolving Relationship.
54:1134-1136.
2012
-
Home-Based HIV Counseling and Testing as a Gateway to Earlier Initiation of Antiretroviral Therapy.
54:282-284.
2012
-
Swine Outbreak of Pandemic Influenza A Virus on a Canadian Research Farm Supports Human-to-Swine Transmission.
52:10-18.
2011
-
The Effect of Universal Influenza Immunization on Antibiotic Prescriptions: An Ecological Study.
49:750-756.
2009
-
Doripenem: A New Carbapenem in the Treatment of Nosocomial Infection.
49:S1-S3.
2009
-
Reply to Meydani and Hamer.
49:479-480.
2009
-
Incidence and Treatment Outcomes of PharyngealNeisseria gonorrhoeaeandChlamydia trachomatisInfections in Men Who Have Sex with Men: A 13‐Year Retrospective Cohort Study.
48:1237-1243.
2009
-
Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study.
48:568-576.
2009
-
Immunosenescence and Vaccination in Nursing Home Residents.
48:443-448.
2009
-
Severe Community‐Acquired Pneumonia (CAP) and the Infectious Diseases Society of America/American Thoracic Society CAP Guidelines Prediction Rule: Validated or Not.
48:386-388.
2009
-
Spectrum of Microbial Etiology of Community‐Acquired Pneumonia in Hospitalized Patients: Implications for Selection of the Population for Enrollment in Clinical Trials.
47:S189-S192.
2008
-
Guideline Tyranny: A Response to the Article by Baum and Kaltsas.
47:1117-1118.
2008
-
Molecular Epidemiology of Candidemia: Evidence of Clusters of Smoldering Nosocomial Infections.
47:e17-e24.
2008
-
Treatment of Community‐Acquired Pneumonia Down Under versus the United States: Is It Really That Different?.
46:1522-1524.
2008
-
Less than 28 Days of Intravenous Antibiotic Treatment Is Sufficient for Suppurative Thrombophlebitis in Injection Drug Users.
46:741-744.
2008
-
Cost-Effectiveness of Herpes Zoster Vaccine: Flawed Assumptions Regarding Efficacy against Postherpetic Neuralgia.
45:1527-1529.
2007
-
Outcomes of Dosage Adjustments Used to Manage Antiretroviral Drug Interactions.
45:933-936.
2007
-
Simple, Effective Interventions Are Key to Improving Adherence in Marginalized Populations.
45:916-917.
2007
-
Throat Swabs Are Necessary to Reliably Detect Carriers of Staphylococcus aureus.
45:475-477.
2007
-
Reply to Collins et al. and to Singh.
45:134-135.
2007
-
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults.
44:S27-S72.
2007
-
Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization.
44:178-185.
2007
-
Prospective, Randomized Inpatient Study of Oral Metronidazole versus Oral Metronidazole and Rifampin for Treatment of Primary Episode ofClostridium difficile–Associated Diarrhea.
43:547-552.
2006
-
Etiologies of Acute Respiratory Tract Infections.
41:503-506.
2005
-
Pneumococcal Serotypes in the Elderly.
41:488-489.
2005
-
A New Paradigm for Clinical Investigation of Infectious Syndromes in Older Adults: Assessment of Functional Status as a Risk Factor and Outcome Measure.
40:114-122.
2005
-
Legionnaires Disease and the Updated IDSA Guidelines for Community‐Acquired Pneumonia.
39:1734-1737.
2004
-
Reply to Yu et al..
39:1737-1738.
2004
-
Respiratory Fluoroquinolones: Differences in the Details.
38:1331-1332.
2004
-
Use of a Broader Determinants of Health Model for Community-Acquired Pneumonia in Seniors.
38:1293-1297.
2004
-
Pneumonia in older persons (vol 37, pg 1335, 2003).
38:308-308.
2004
-
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults.
37:1405-1433.
2003
-
Pneumonia in Older Persons.
37:1335-1339.
2003
-
Editorial Commentary: Short‐Course Treatment of Community‐Acquired Pneumonia.
37:761-763.
2003
-
Editorial Commentary: What is Optimal Antimicrobial Therapy for Bacteremic Pneumococcal Pneumonia?.
36:396-398.
2003
-
Geographical Differences in Human Oral Yeast Flora.
36:221-224.
2003
-
The Battle against Emerging Antibiotic Resistance: Should Fluoroquinolones Be Used to Treat Children?.
35:721-727.
2002
-
Severe Group A Streptococcal Soft-Tissue Infections in Ontario: 1992–1996.
34:454-460.
2002
-
Antimicrobial Safety and Tolerability: Differences and Dilemmas.
32:S72-S79.
2001
-
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.
31:383-421.
2000
-
Guidelines for Community-Acquired Pneumonia: A Tale of 2 Countries.
31:422-425.
2000
-
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults.
31:347-382.
2000
-
Community‐Acquired Pneumonia in Adults: Guidelines for Management.
26:811-838.
1998
-
An outbreak of variably vancomycin dependent enterococcus.
25:363.
1997
-
Intra-abdominal and psoas absceas secondary to Mvcobacterium avium complex in a patient with human immunodeficiency virus infection.
25:462.
1997
-
Mycobacterium xenopiInfection in Patients with Human Immunodeficiency Virus Infection.
25:206-210.
1997
-
Histoplasmosis and Kidney Disease in Patients with AIDS.
25:281-284.
1997
-
Single Daily Dosing of Aminoglycosides in Immunocompromised Adults: A Systematic Review.
24:810-815.
1997
-
Respiratory Infections: Diagnosis and Management By James E. Pennington. 3rd ed. New York: Raven Press, 1994. 881 pp., illustrated. $99.
20:733-734.
1995
-
An Economic Evaluation of Varicella Vaccine for Pediatric Liver and Kidney Transplant Recipients.
17:441-447.
1993
-
Menstrual Toxic Shock Syndrome Complicated by Persistent Bacteremia: Case Report and Review.
16:288-289.
1993
-
Zidovudine for Chemoprophylaxis after Occupational Exposure to HIV-Infected Blood: An Economic Evaluation.
14:822-830.
1992
-
Current Advances in Viral Diagnostic Technology Applicable to Polio Vaccination and Diagnosis.
6:S525-S527.
1984
-
Effects of Antimicrobial and Antineoplastic Drugs on the Phagocytic and Microbicidal Function of the Polymorphonuclear Leukocyte.
4:683-697.
1982
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)